PVR and acute myeloid leukemia: Contrary to previous findings, Stamm et al. reported that TIGIT ligands - CD155 and CD112 are highly expressed on AML cells and blockade of TIGIT-CD155/CD112 axis significantly increased lysis of leukemic cells in vitro in a culture with healthy whole PBMCs (peripheral blood mononuclear cells) [96].